XML 52 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders’ Equity

9. Stockholders’ Equity

Common Stock Offerings

In April 2018, we sold 6.9 million shares of our common stock at a public offering price of $26.00 per share. We received total net proceeds of $168.7 million (net of $10.7 million in issuance costs) from the sale of the common stock.

In June 2018, we sold 5.1 million shares of our common stock at a public offering price of $39.50 per share. We received total net proceeds of $194.4 million (net of $5.6 million in issuance costs) from the sale of the common stock.

Stock Option Activity

The following table summarizes the stock option activity for the three months ended September 30, 2019:

 

 

 

Shares

(in thousands)

 

 

Weighted-

average

Exercise Price

 

 

Weighted-

average

Remaining

Contractual

Term (Years)

 

Balance at December 31, 2018

 

 

15,265

 

 

$

18.33

 

 

 

6.87

 

Granted

 

 

985

 

 

$

21.18

 

 

 

 

 

Exercised

 

 

(1,793

)

 

$

11.29

 

 

 

 

 

Expired and forfeited

 

 

(1,378

)

 

$

22.65

 

 

 

 

 

Balance at September 30, 2019

 

 

13,079

 

 

$

19.06

 

 

 

7.34

 

 

For the nine months ended September 30, 2019, 1,793,000 shares of common stock were issued pursuant to the exercise of stock options, resulting in net proceeds of $20.2 million.

Stock-based Compensation

The following table summarizes stock-based compensation expense related to stock-based payment awards granted pursuant to all of our equity compensation arrangements (in thousands):

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Research and development

 

$

4,365

 

 

$

3,212

 

 

$

14,123

 

 

$

9,363

 

General and administrative

 

 

2,939

 

 

 

2,366

 

 

 

10,333

 

 

 

6,950

 

Sales and marketing

 

 

2,400

 

 

 

2,472

 

 

 

15,856

 

 

 

7,259

 

Total stock-based compensation expense

 

$

9,704

 

 

$

8,050

 

 

$

40,312

 

 

$

23,572

 

 

As of September 30, 2019, there was $80.2 million of total unrecognized compensation cost related to non-vested, stock-based payment awards granted under all of our equity compensation plans and all non-plan option grants. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. We expect to recognize this compensation cost over a weighted-average period of 2.6 years.

We estimated the fair value of each option grant on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Risk-free interest rate

 

 

2.1

%

 

 

2.8

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

Volatility

 

 

67.4

%

 

 

70.5

%

Expected life (years)

 

 

6

 

 

 

6

 

 

We estimated the fair value of each purchase right granted under our 1997 Employee Stock Purchase Plan, as amended, at the beginning of each new offering period using the Black-Scholes option pricing model. There were no new offering periods for the three months ended September 30, 2019 and 2018.